Unknown

Dataset Information

Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial.


ABSTRACT:

Purpose

Patients suffering from recurrent and residual grade 2 (WHO) meningiomas after subtotal excision should be considered as high-risk groups with an uncertain prognosis. Adjuvant radiotherapy seems to be the best approach to reduce disease progression. The primary aim of this phase II explorative, monocentric, single arm study was to evaluate the safety of adjuvant multisession radiosurgery (mRS) in this group of patients; the efficacy in terms of tumour local control was the secondary endpoint.

Methods

Patients recruited from April 2017 to May 2019 were over 18 years old, had a histologically-documented intracranial recurrent or residual Grade 2 meningioma (WHO 2016) and a KPS > 70. Patients with NF2, concomitant neoplasm or pregnancy were excluded. Descriptive statist

SUBMITTER: Marchetti M 

PROVIDER: S-EPMC8979484 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature